Related Experiment Video
Updated: Aug 7, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Totally endoscopic robot-assisted transmyocardial laser revascularization
Louis A Brunsting1, Robert S Binford, Kimberly C Braly
1The Heart Team, Centennial Medical Center, Nashville, Tennessee, USA. lab.theheartteam@comcast.net
The Annals of Thoracic Surgery
|July 26, 2006
Summary
This study details the first robot-assisted transmyocardial laser revascularization procedure in a patient with severe coronary artery disease. The minimally invasive surgery successfully relieved refractory angina symptoms, offering a new option for complex cases.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Procedures
- Robotic Surgery
Background:
- Refractory angina in patients with diffuse coronary atherosclerotic disease poses a significant treatment challenge.
- Prior coronary bypass operations can limit options for revascularization.
- Transmyocardial laser revascularization (TMLR) is an option for patients unsuitable for conventional revascularization.
Observation:
- A 58-year-old male patient with refractory rest angina and prior coronary bypass surgery presented with left ventricular apex ischemia.
- Conventional revascularization techniques were not suitable due to diffuse coronary atherosclerotic disease.
- The patient underwent a totally endoscopic, off-pump, robot-assisted TMLR procedure.
Findings:
- The da Vinci robotic system was used to precisely create 25 transmural channels in the left ventricular myocardium.
- The procedure was performed using a fiberoptic laser delivery system.
- Postoperative recovery was rapid and uneventful.
Implications:
- This case demonstrates the feasibility and potential efficacy of totally endoscopic, off-pump, robot-assisted TMLR.
- This technique may offer a viable alternative for patients with complex coronary artery disease and refractory angina.
- Successful symptom relief suggests potential for improved quality of life in select patient populations.
